Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4870974
Max Phase: Preclinical
Molecular Formula: C39H53N2O11P
Molecular Weight: 756.83
Molecule Type: Unknown
Associated Items:
ID: ALA4870974
Max Phase: Preclinical
Molecular Formula: C39H53N2O11P
Molecular Weight: 756.83
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOP(=O)(/C=C/C(NC(=O)[C@H](CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3)NC(=O)OCc1ccccc1)c1ccccc1)OCC
Standard InChI: InChI=1S/C39H53N2O11P/c1-6-47-53(44,48-7-2)23-21-32(29-16-12-9-13-17-29)40-34(42)33(41-37(43)46-24-28-14-10-8-11-15-28)25-45-35-27(4)31-19-18-26(3)30-20-22-38(5)50-36(49-35)39(30,31)52-51-38/h8-17,21,23,26-27,30-33,35-36H,6-7,18-20,22,24-25H2,1-5H3,(H,40,42)(H,41,43)/b23-21+/t26-,27-,30+,31+,32?,33+,35+,36-,38-,39-/m1/s1
Standard InChI Key: QRSNFCBGLDWPJL-ZYENLXRASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 756.83 | Molecular Weight (Monoisotopic): 756.3387 | AlogP: 7.14 | #Rotatable Bonds: 15 |
Polar Surface Area: 149.11 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.52 | CX Basic pKa: | CX LogP: 6.43 | CX LogD: 6.43 |
Aromatic Rings: 2 | Heavy Atoms: 53 | QED Weighted: 0.14 | Np Likeness Score: 1.39 |
1. Aratikatla EK, Kalamuddin M, Rana KC, Datta G, Asad M, Sundararaman S, Malhotra P, Mohmmed A, Bhattacharya AK.. (2021) Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials., 220 [PMID:33901900] [10.1016/j.ejmech.2021.113454] |
Source(1):